Recently, studies found that UCA1 was effective to enhance the activities of Wnt/β-catenin in several types of cancers including melanoma [21], breast cancer [17], osteosarcoma [22] and oral squamous cell carcinoma [23]. The gene discussed is UCA1; the disease is breast carcinoma.